Marshall Wace North America’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BBA
AC
CS
SC
Marshall Wace North America's BLUE Position: Q3 2021 in Review
Marshall Wace North America sold out of bluebird bio (BLUE) in Q3 2021, closing a stake of 3,857 shares — an estimated $1.6M sold.
Marshall Wace North America first reported a position in BLUE in Q3 2013 and held it in 14 quarters. The position peaked at $74.9M in Q1 2019. 196 funds tracked by Wall St. Rank hold BLUE as of Q3 2021.
- Marshall Wace North America reported no remaining bluebird bio position as of Q3 2021 after selling out during the quarter.
- Marshall Wace North America sold 3,857 bluebird bio shares in Q3 2021, an estimated $1.6M.
- Marshall Wace North America first reported a position in bluebird bio in Q3 2013 and held it in 14 quarters.
- Marshall Wace North America's bluebird bio position peaked at $74.9M in Q1 2019.
- 196 funds tracked by Wall St. Rank held bluebird bio as of Q3 2021.
Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.